Working… Menu
Trial record 1 of 1 for:    BMN 270-203
Previous Study | Return to List | Next Study

Gene Therapy Study in Severe Hemophilia A Patients With Antibodies Against AAV5 (270-203)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03520712
Recruitment Status : Enrolling by invitation
First Posted : May 11, 2018
Last Update Posted : December 23, 2020
Information provided by (Responsible Party):
BioMarin Pharmaceutical

No Study Results Posted on for this Study
Recruitment Status : Enrolling by invitation
Estimated Primary Completion Date : November 2026
Estimated Study Completion Date : November 2026